NURTURING HEALTH, NATURALLY: YOUR ACCESS MATTERS.
Delta-9 Medicinal
In Australia, most cannabis products, including CBD oil, are unapproved prescription medicines, requiring doctors to follow specific protocols for prescribing. Patients with medical conditions can access medicinal cannabis through various pathways. The Therapeutic Goods Administration (TGA) advises that medical cannabis is not a primary treatment and should only be considered if conventional medications fail or cause adverse effects, except in palliative care. Patients should consult their usual doctor, who may prescribe cannabis if deemed suitable.
Delta 9: Your Gateway To Healing
How to Access Medical Cannabis
In Australia, most cannabis products are yet to receive approval as registered prescription medicines, requiring doctors to follow a specific protocol for prescribing these treatments.
Patients diagnosed with a medical condition have various pathways to access medicinal cannabis, despite its status as an unapproved product within the country.
It's important to note that according to the Therapeutic Goods Administration (TGA), medical cannabis is generally not considered a primary treatment. As such, cannabinoid-based therapy is typically reserved for instances where conventional prescription medications have not yielded success or have resulted in adverse side effects, with the exception of palliative care scenarios.
Explore
We Help You Understand
How to Access
Patients diagnosed with a medical condition have various pathways to access medicinal cannabis.
Step-By-Step Guide
Delta 9's Guide to Medical Cannabis: Eligibility and Access is a concise. Unsure and need a guide?
Costs Involved
There are various factors that contribute to the cost of cannabis. Click here to understand more.
Talk To a doctor
It's best to start the discussion with your current healthcare provider to ascertain if they are open to prescribing it.
Empowering Knowledge
Explore Insights and Resources on Medicinal Marijuana Education
Landmark Trial Explores the Potential of Cannabis in Treating Chronic Insomnia
In a ground-breaking initiative, researchers are embarking on a world-first trial to investigate the therapeutic potential of cannabis in alleviating chronic insomnia, a condition that affects one in three Australians....
TGA Enforces New Standards for Medicinal Cannabis Quality, Packaging, and Labelling
Commencing July 1, 2023, the Therapeutic Goods Administration (TGA) has instituted transformative alterations to the requirements governing the quality, packaging, and labelling of medicinal cannabis products in Australia. These comprehensive...
Australian Study Reveals Positive Impact of Medical Cannabis on Quality of Life
Australian researchers have uncovered compelling evidence suggesting that medical cannabis can have a substantial positive effect on the quality of life for individuals grappling with various health conditions. This peer-reviewed...